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Observations on the relationship between cardiac work rate and the levels of energy metabolites adenosine
triphosphate (ATP), adenosine diphosphate (ADP), and phosphocreatine (CrP) have not been satisfactorily explained
by theoretical models of cardiac energy metabolism. Specifically, the in vivo stability of ATP, ADP, and CrP levels in
response to changes in work and respiratory rate has eluded explanation. Here a previously developed model of
mitochondrial oxidative phosphorylation, which was developed based on data obtained from isolated cardiac
mitochondria, is integrated with a spatially distributed model of oxygen transport in the myocardium to analyze data
obtained from several laboratories over the past two decades. The model includes the components of the respiratory
chain, the F0F1-ATPase, adenine nucleotide translocase, and the mitochondrial phosphate transporter at the
mitochondrial level; adenylate kinase, creatine kinase, and ATP consumption in the cytoplasm; and oxygen transport
between capillaries, interstitial fluid, and cardiomyocytes. The integrated model is able to reproduce experimental
observations on ATP, ADP, CrP, and inorganic phosphate levels in canine hearts over a range of workload and during
coronary hypoperfusion and predicts that cytoplasmic inorganic phosphate level is a key regulator of the rate of
mitochondrial respiration at workloads for which the rate of cardiac oxygen consumption is less than or equal to
approximately 12 lmol per minute per gram of tissue. At work rates corresponding to oxygen consumption higher
than 12 lmol min
 1 g
 1, model predictions deviate from the experimental data, indicating that at high work rates,
additional regulatory mechanisms that are not currently incorporated into the model may be important. Nevertheless,
the integrated model explains metabolite levels observed at low to moderate workloads and the changes in metabolite
levels and tissue oxygenation observed during graded hypoperfusion. These findings suggest that the observed
stability of energy metabolites emerges as a property of a properly constructed model of cardiac substrate transport
and mitochondrial metabolism. In addition, the validated model provides quantitative predictions of changes in
phosphate metabolites during cardiac ischemia.
Citation: Beard DA (2006) Modeling of oxygen transport and cellular energetics explains observations on in vivo cardiac energy metabolism. PLoS Comput Biol 2(9): e107.
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Introduction
Over 30 years ago, Neely et al. [1] showed that adenosine
triphosphate (ATP), adenosine diphosphate (ADP), and
adenosine monophosphate (AMP) concentrations are main-
tained at essentially constant concentrations with changes in
cardiac work in the isolated perfused heart. Twenty years ago,
Balaban et al. [2] observed that energetic phosphate concen-
trations measured in vivo using NMR spectroscopy remain
effectively constant over a range of cardiac workloads. These
observations contradicted earlier models of the control of
mitochondrial metabolism, which assumed that the rate of
oxidative phosphorylation was regulated primarily by the
availability of ADP [3,4]. Speciﬁcally, the cytoplasmic ADP
concentration and the ratio of creatine phosphate (CrP) to
ATP concentration was found to be approximately constant
over a range of workload and rates of oxygen consumption in
canine hearts [2,5]. To date, a credible validated biophysical
model of the in vivo regulation of oxidative phosphorylation
that explains the observed phenomena has not been
established. Such a model would provide a theoretical basis
for understanding how mitochondrial metabolism is regu-
lated in response to changing ATP turnover rate while
maintaining homeostatic concentrations of ATP, ADP, and
CrP. Such a model would also form the basis of quantitative
studies of the regulation of phosphate metabolites oxidative
phosphorylation in the failing heart and other pathophysio-
logical situations [6].
In this work, a detailed model of cardiac oxidative
phosphorylation that was developed based on an extensive
set of data obtained from isolated mitochondria [7] is
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transport and exchange with tissue [8]. The mitochondrial
model includes the components of the respiratory chain, the
F0F1-ATPase, adenine nucleotide translocase, and the mito-
chondrial phosphate transporter. The mitochondrial model
is integrated with a model of ATP, ADP, AMP, and CrP
metabolism in the cytoplasm, including the reactions of
adenylate kinase, creatine kinase, and ATP consumption.
Oxygen transport is governed by advection of blood in
capillaries, passive permeation between blood and interstitial
ﬂuid and between interstitial ﬂuid and cardiomyocytes, and
metabolic consumption at Complex IV of the respiratory
chain. An empiric relationship between cardiac perfusion
and ATP consumption rate is determined by comparing
model simulations to data published by Katz et al. [5]. The
behavior of the resulting integrated model is compared to
datasets published by Katz et al. [5], Portman et al. [9], and
Zhang et al. [10], which report on in vivo changes in cardiac
phosphate metabolites in response to changes in workload
and to graded ischemia.
Results
Overview of Oxygen Transport
Oxygen transport and energetic metabolism in cardiac
tissue are simulated using a three-region one dimensionally
distributed model [8,11], illustrated in Figure 1. The model
assumes that within the capillary, interstitial space, and
cellular (myocyte) space, the concentrations of oxygen and
other metabolites vary primarily along the length of the
capillary. Advective transport is modeled in the capillary
region; the interstitial and cellular spaces are assumed to be
stagnant (nonﬂowing). The cellular region is further sub-
divided into cytoplasmic and mitochondrial compartments,
as described below. The full set of model variables is listed in
Table 1, along with a brief description of the variables and the
units associated with each variable. Note that oxygen
concentrations are expressed as mass per unit volume, while
the other intracellular species are expressed as mass per unit
water volume in a given region. Each variable in the model is
a function of distance along the capillary x and time t.
A representative model-predicted steady-state oxygen
concentration proﬁle is illustrated in Figure 1B, which plots
the capillary, interstitial, and cellular PO2 as functions of x/L,
the normalized distance along the capillary. Partial pressures
decrease from the arterial (x¼0) to the venous (x¼L) end of
the capillary and decrease from the capillary region to the
cellular region.
To obtain the results illustrated in Figure 1B, the total pool
of exchangeable phosphate in the cell (see Equation 26 in
Materials and Methods) was set to 15 mM, ﬂow was set to G¼
0.75 ml min
 1 (g of tissue)
 1,a n dt h er a t eo fA T P
consumption was set to JAtC ¼ 0.45 mmol s
 1 (l cell)
 1. For
all simulations, the input arterial PO2 was assumed to be 100
mm Hg. For these values, the rates of oxygen consumption
and oxygen extraction were found to be 5.3 lmol min
 1 (g of
Figure 1. Axially Distributed Blood–Tissue Exchange Model for Oxygen
Transport
(A) A three-region one dimensionally distributed model for oxygen
transport is diagrammed. The three regions correspond to capillary,
interstitium, and cell (myocyte). Blood flows in the capillary region.
Oxygen is transported via passive permeation between the capillary,
interstitial, and myocyte regions.
(B) Predicted capillary, interstitial, and cellular PO2 are plotted as
functions of x/L, the normalized distance along the capillary. Simulation
parameters are TPP¼15 mM, G¼0.75 ml min 1 (g of tissue) 1, and JAtC¼
0.45 mmol s
 1 (l cell)
 1. The input arterial PO2 is assumed to be 100 mm
Hg. The predicted rate of oxygen consumption and oxygen extraction
are found to be 5.3 lmol min 1 (g of tissue) 1 and 76%, respectively.
DOI: 10.1371/journal.pcbi.0020107.g001
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Synopsis
To function properly over a range of work rates, the heart must
maintain its metabolic energy level within a range that is narrow
relative to changes in the rate of energy utilization. Decades of
observations have revealed that in cardiac muscle cells, the supply
of adenosine triphosphate (ATP)—the primary currency of intra-
cellular energy transfer—is controlled to maintain intracellular
concentrations of ATP and related compounds within narrow
ranges. Yet the development of a mechanistic understanding of
this tight control has lagged behind experimental observation. This
paper introduces a computational model that links ATP synthesis in
a subcellular body called the mitochondrion with ATP utilization in
the cytoplasm, and reveals that the primary control mechanism
operating in the system is feedback of substrate concentrations for
ATP synthesis. In other words, changes in the concentrations of the
products generated by the utilization of ATP in the cell (adenosine
diphosphate and inorganic phosphate) effect changes in the rate at
which mitochondria utilize those products to resynthesize ATP.
Cardiac Energeticstissue)
 1 and 76%, respectively, values which are consistent
with a moderate rate of cardiac work [12,13].
Relationship between Flow and ATP Consumption
To simulate the behavior of the model at different
workloads, it is necessary to deﬁne a relationship between
workload and coronary perfusion. In Katz et al. [5], cardiac
ﬂow and the rate of cardiac oxygen consumption, MVO2, are
measured under different conditions. Yet in the integrated
model, MVO2 is not set as an input parameter; MVO2 is
computed as a function of the rate of ATP consumption JAtC.
To determine a relationship between G and JAtC, the model
was ﬁt to data from Tables 2, 3, and 4 of Katz et al. [5], which
report G and MVO2 for paced hearts, hearts stimulated with
epinephrine, and hearts stimulated with phenylephrine. For
entry in these tables, the value of JAtC was varied until the
model-predicted MVO2 was equal to the given experimental
measure. The resulting data are plotted in Figure 2A. The
observed G and JAtC values approximately obey the linear
relationship G ¼ 0.3326 þ (2.315)JAtC, where JAtC is expressed
in units of mmol s
 1 (l cell)
 1 and G is computed in units of ml
min
 1 (g of tissue)
 1. The linear ﬁt between the ﬂow and ATP
consumption rate is indicated by the straight line in the
ﬁgure. This relationship is used to specify a value of G to use
for simulating the system behavior at a given rate of JAtC in
the following section.
Figure 2B illustrates the predicted relationship between
mitochondrial ATP production and oxygen consumption
over the range a range of JAtC values from 0 to 1.7 mmol s
 1 (l
cell)
 1. The P/O ratio is the ratio of the rate of ATP synthesis
by the F0F1-ATPase to the rate of consumption of oxygen
atoms. At JAtC ¼ 0, the P/O ratio is 0 because no ATP is
synthesized while a ﬁnite oxygen consumption ﬂux exists to
offset the rate of proton leak across the inner mitochondrial
membrane. At high values of ATP consumption (and oxygen
consumption), the P/O ratio approaches the theoretical
maximum of 2.50 for the oxidative phosphorylation model
of Beard [7].
Phosphate Metabolites as a Function of Workload
Using the developed linear relationship between workload
and coronary ﬂow, steady-state model predictions were
Table 1. Model Variables
Variable Description Units
CO,1 Oxygen concentration in blood mol (l blood)
 1
CO,2 Oxygen concentration in interstitial fluid mol (l ISF)
 1
CO,3 Oxygen concentration in myocyte mol (l cell)
 1
P1 Oxygen partial pressure in blood mm Hg
P2 Oxygen partial pressure in interstitial fluid mm Hg
P3 Oxygen partial pressure in myocyte mm Hg
SHb Hemoglobin saturation in red blood cells unitless
SMb Myoglobin saturation unitless
[H
þ]x Concentration of H
þ ion in mito matrix mol (l matrix water)
 1
[K
þ]x Concentration of K
þ ion in mito matrix mol (l matrix water)
 1
[Mg
2þ]x Concentration of Mg
2þ ion in mito matrix mol (l matrix water)
 1
[NADH]x Concentration of NADH in mito matrix mol (l matrix water)
 1
[NAD]x Concentration of NAD in mito matrix mol (l matrix water)
 1
[QH2]x Concentration of reduced ubiquinol in mito matrix mol (l matrix water)
 1
[Q]x Concentration of oxidized ubiquinol in mito matrix mol (l matrix water)
 1
[ATP]x Concentration of total ATP in mito matrix mol (l matrix water)
 1
[ADP]x Concentration of total ADP in mito matrix mol (l matrix water)
 1
[mATP]x Concentration of Mg
2þ-bound ATP in mito matrix mol (l matrix water)
 1
[mATP]x Concentration of Mg
2þ-bound ADP in mito matrix mol (l matrix water)
 1
[Pi]x Concentration of Pi in mito matrix mol (l matrix water)
 1
[cytoC(red)
2þ]i Concentration of reduced cytochrome c in IM space mol (l IM water)
 1
[cytoC(ox)
3þ]i Concentration of oxidized cytochrome c in IM space mol (l IM water)
 1
[ATP]i Concentration of total ATP in IM space mol (l IM water)
 1
[ADP]i Concentration of total ADP in IM space mol (l IM water)
 1
[AMP]i Concentration of total AMP in IM space mol (l IM water)
 1
[mATP]i Concentration of Mg
2þ-bound ATP in IM space mol (l IM water)
 1
[mADP]i Concentration of Mg
2þ-bound ADP in IM space mol (l IM water)
 1
[Pi]i Concentration of Pi in IM space mol (l IM water)
 1
[Mg
2þ]i Concentration of Mg
2þ ion in IM space mol (l IM water)
 1
[ATP]c Concentration of total ATP in cytoplasm mol (l cytoplasm water)
 1
[ADP]c Concentration of total ADP in cytoplasm mol (l cytoplasm water)
 1
[AMP]c Concentration of total ADP in cytoplasm mol (l cytoplasm water)
 1
[mATP]c Concentration of Mg
2þ-bound ATP in cytoplasm mol (l cytoplasm water)
 1
[mADP]c Concentration of Mg
2þ-bound ADP in cytoplasm mol (l cytoplasm water)
 1
[Mg
2þ]c Concentration of free Mg
2þ ion in cytoplasm mol (l cytoplasm water)
 1
[Pi]c Concentration of Pi in cytoplasm mol (l cytoplasm water)
 1
[CrP]c Concentration of creatine phosphate in cytoplasm mol (l cytoplasm water)
 1
[Cr]c Concentration of creatine in cytoplasm mol (l cytoplasm water)
 1
DW Mitochondrial membrane potential mV
DOI: 10.1371/journal.pcbi.0020107.t001
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Cardiac Energeticscalculated for a range of JAtC values from 0 to 1.7 mmol s
 1 (l
cell)
 1. Over this range, the predicted MVO2 varies from 1.68
lmol min
 1 (g of tissue)
 1 to 15.7 lmol min
 1 (g of tissue)
 1.
Predictions of ADP and Pi concentrations and CrP/ATP ratio
as functions of MVO2 are plotted in Figure 3. In Figure 3,
concentrations of metabolites are computed as the average
value in the distributed model for a given steady-state
condition.
The black curves in Figure 3A represent the relative
cytoplasmic ADP level (normalized to the value at JAtC¼0) as
a function of MVO2 for three different values of the total
phosphate pool parameter (see Equation 26 in Materials and
Methods). Also plotted are data from Figures 2A, 4A, and 6A
of Katz et al. [5], which represent experimental observations
for the three different stimulus protocols described above. It
is apparent that within the range of observed variability, the
model predictions match the experimental data for values of
MVO2, less than approximately 12 lmol min
 1 (g of tissue)
 1.
At the highest simulated level of TPP (18 mM), the model
predictions diverge from the observed data at MVO2 values
slightly lower than is predicted at TPP equal to 12 mM and 15
mM. However, regardless of the value of TPP, the model
predicts that the relative ADP concentration is 2-fold to 3-
fold higher at MVO2 ¼ 15 lmol min
 1 (g of tissue)
 1 than at
the lower work rates. Although the amount of available data
for extremely high workloads near MVO2¼15 lmol min
 1 (g
of tissue)
 1 is sparse, the observations indicate that even at
these extreme work rates, the cellular ADP level does not
signiﬁcantly increase from the minimum value.
Figure 3B plots the predicted CrP/ATP ratio in the
cytoplasm as a function of MVO2, as well as the data from
Figures 2C, 4C, and 6C of Katz et al. [5]. Model predictions at
TPP¼15 mM are most consistent with the experimental data.
At this value for the total phosphate pool, the model predicts
that the ratio CrP/ATP drops from 2 at low work rate to
approximately 1 at the highest work rate. Over the range of
MVO2 from 2 to 6 lmol min
 1 (g of tissue)
 1, the predicted
CrP/ATP ranges from 1.89 to 1.76 at TPP ¼ 15 mM.
Model-predicted concentrations of cytoplasmic Pi as a
function of work rate are plotted in Figure 3C. The model
predicts thatat TPP¼15 mM,[Pi]c increases from0.02 mMat 0
workload to 0.36 mM at MVO2¼6 lmol min
 1 (g of tissue)
 1 to
3.1 mM at MVO2 ¼ 15 lmol min
 1 (g of tissue)
 1. Over the
range for which the model best ﬁts the observed data on ADP
and CrP/ATP [MVO2 ¼ 1.68 to 12 lmol min
 1 (g of tissue)
 1],
the model predicts that Pi concentration increases from 0.02
mM to 1.6 mM. While it is difﬁcult to absolutely quantify Pi
concentration in vivo in the heart from
31P-NMR spectro-
scopy, it is possible to estimate changes in the amount of Pi
relative to other phosphate metabolites. Zhang et al. [14]
report DP/CrP in the canine heart—the change in Pi relative
to phosphocreatine—from baseline to maximally stimulated
contraction to be 0.21. This value of DP/CrP corresponds to a
change in Pi of approximately 2 mM, which is consistent with
our model predictions.
In Figure 3D, the predicted MVO2 is plotted as a function
of absolute cytoplasmic ADP concentration. For comparison,
data obtained from in vivo hearts of newborn (open squares)
and adult (shaded triangles) from Portman et al. [9] are
plotted in Figure 3D. Cytoplasmic ADP concentration is
predicted to be approximately 0.1 to 0.15 mM in low and
moderate workload conditions at the preferred value of TPP
¼ 15 mM.
Figure 3E illustrates that cytoplasmic ATP concentration
remains constant (with less than 10% variation) over the
simulated range of work rate for all values of TPP. Thus the
predicted variation in CrP/ATP ratio is due to changes in the
CrP concentration, as illustrated in Figure 3F, which plots
cytoplasm CrP as a function of MVO2.
Based on the above calculations, the parameter TPP is set
to 15 mM for the remaining simulations.
Cytoplasmic versus Mitochondrial Metabolite Pools
As described above, the solid curves in Figure 3 represent
the predicted levels of ADP, CrP/ATP, and Pi in the cytoplasm.
Comparing these values to the data of Katz et al. [5] is
consistent with assumptions made in that paper that an
Figure 2. Relationships between ATP Consumption Rate, Blood Flow, and Rate of Oxygen Consumption in Cardiac Tissue
(A) Plot of coronary flow from Tables 2, 3, and 4 of Katz et al. [5] as a function of predicted rate of ATP consumption, JAtC. The values of JAtC were
estimated by matching the model-predicted rate of oxygen consumption, MVO2, to the reported experimentally measured estimates of MVO2. Circles,
squares, and triangles represent data from pacing protocol (Table 2 of [5]), epinephrine protocol (Table 3 of [5]), and phenylephrine protocol (Table4o f
[5]), respectively. The solid line represents the best fit to the data, G¼0.3326þ(2.315)JAtC, where JAtC is expressed in units of mmol s
 1 (l cell)
 1 and G is
computed in units of ml min
 1 (g of tissue)
 1.
(B) The predicted ratio between mitochondrial ATP production and rate of oxygen atom consumption (P/O ratio) is plotted for JAtC values from 0 to 1.7
mmol s
 1 (l cell)
 1.A tJAtC¼0, the predicted MVO2 is 1.68 lmol min
 1 (g of tissue)
 1, corresponding to the oxygen consumption rate necessary to offset
rate of proton leak across the inner mitochondrial membrane.
DOI: 10.1371/journal.pcbi.0020107.g002
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Cardiac Energeticsexperimental estimate for cytoplasmic ADP concentration
can be obtained from the equation [ADP] ¼ [ATP][Cr]/
KCK[CrP][H
þ]. The application of this equation to exper-
imental data on [ATP] and [CrP]/[Cr] is based on two
assumptions: 1) that the measured levels of both ATP and
CrP represent concentrations in the cytoplasm and 2) that the
creatine kinase (CK) reaction is maintained in equilibrium.
This standard assumption is invoked, for example, in the
studies of Balaban and coworkers [2,5,9]. However, Garlick
and coworkers [15–17] ﬁnd that both the cytoplasmic and
mitochondrial ATP pools are visible in
31P NMR spectroscopy.
If this were the case, then it would not be appropriate to
assume that the total adenine nucleotide pool is in chemical
equilibrium with the Cr and CrP, and consequently the
reported relative ADP concentrations would not represent
unbiased estimates of cytoplasmic ADP. The current model
predicts that the total (cytoplasmic plus mitochondrial) ADP
pool (plotted as dashed line in Figure 3A) is effectively
constant over the full range of work rate simulated.
Predicted State Variables at Different Workloads
While the previous section illustrates the spatially averaged
cardiac phosphate metabolite levels at different steady-state
Figure 3. Comparison of the Model Simulations to Experiment Data on Energetic Phosphate Compounds in Cardiac Tissue at Varying Cardiac Work Rate
(A) Normalized ADP is plotted as a function of MVO2. Solid lines correspond to model simulations of cytoplasmic ADP at different values of total
phosphate pool, TPP¼12, 15, and 18 mM. Dashed line represents total relative ADP mass (cytoplamic plus mitochondrial) predicted for TPP¼15 mM.
(B) Ratio cytoplasmic CrP/ATP is plotted as a function of MVO2. Solid lines correspond to model simulations at different values of total phosphate pool,
TPP ¼ 12, 15, and 18 mM.
(C) Cytoplasm Pi concentration is plotted as a function of MVO2.
(D) Predicted MVO2 is plotted as a function of predicted ADP concentration in cytoplasm. Solid lines correspond to model simulations at different values
of total phosphate pool, TPP ¼ 12, 15, and 18 mM, indicated in figure. Experimental data in (A) and (B) are obtained from Katz et al. [5]; data in (D) is
obtained from Portman et al. [9]. In all panels, model curves are obtained by varying JAtC from 0 to 1.7 mmol s
 1 (l cell)
 1 and setting flow according to
G ¼ 0.3326 þ (2.315)JAtC, where JAtC is expressed in units of mmol s
 1 (l cell)
 1 and G is computed in units of ml min
 1 (g of tissue)
 1.
(E) Predicted cytoplasmic ATP concentration is plotted as a function of predicted MVO2.
(F) Predicted cytoplasmic CrP concentration is plotted as a function of predicted ADP concentration in cytoplasm.
DOI: 10.1371/journal.pcbi.0020107.g003
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Cardiac Energeticswork rates, in this section predicted spatial proﬁles of model
variables are explored at two different work rates. Speciﬁ-
cally, simulations were performed at JAtC ¼ 0.45 mmol s
 1 (l
cell)
 1 and G ¼ 0.75 ml min
 1 (g of tissue)
 1 (deﬁned as
moderate work rate) and at JAtC¼0.90 mmol s
 1 (l cell)
 1 and G
¼ 1.25 ml min
 1 (g of tissue)
 1 (deﬁned as high work rate). At
the moderate work rate, oxygen consumption and extraction
were computed to be 5.3 lmol min
 1 (g of tissue)
 1 and 76%;
at the high work rate, oxygen consumption and extraction
were computed to be 9.1 lmol min
 1 (g of tissue)
 1 and 78%.
The predicted values of venous PO2 are 18.5 mm Hg and 17.9
mm Hg for the moderate and high work rates, respectively.
Predicted spatial proﬁles of nine state variables are plotted
in Figure 4, with solid lines and dashed lines representing
data from the moderate and high work rates, respectively.
From Figure 4A, it is apparent that at the high work rate,
cellular PO2 approaches 0 near the venous end of the
capillary. At the moderate work rate, the minimum cellular
PO2 is 10.6 mm Hg; the minimum cellular PO2 at the high work
rate is 2.9 mm Hg. Although the cellular PO2 varies along the
length of the capillary, it is apparent that at a given workload,
most of the state variables remain relatively constant
throughout the cell region. Mitochondrial NADH and
cytoplasmic ADP and Pi are predicted to be slightly elevated
in the region of lowest oxygenation at the high work rate; DW
is 2 mV to 3 mV lower in the region of low oxygen at the high
work rate than it is for the majority of the myocyte space. The
cytoplasmic ATP concentration (Figure 4F) is approximately
98% of the total adenine nucleotide pool at moderate and
high work rates. The cellular Pi concentration is predicted to
increase from approximately 0.3 mM at moderate work to
approximately 1 mM at high work.
Phosphate Metabolites during Graded Hypoperfusion
To explore the behavior of the integrated model during
ischemia, when the tissue may become hypoxic to an extent
greater than that observed in the simulations described
above, it is not possible to treat the ATP consumption ﬂux as
a constant that does not depend on the available cytoplasmic
ATP. To ensure that ATP concentration is not allowed to
become negative, it is necessary to model the ATP con-
sumption ﬂux using an expression that approaches 0 as ATP
concentration approaches 0. In this section, in which the
high-energy phosphate metabolic response of cardiac tissue
to graded hypoperfusion is simulated, the ATP consumption
ﬂux is modeled using the expression
JAtC ¼ VAtC
½ATP c
½ATP c þ 10½ADP c
; ð1Þ
where the ﬂux approaches the constant VAtC under normal
conditions when ATP concentrations are more than 50 times
higher than cytoplasm ADP concentrations.
Figure 4. Spatial Profiles of Model Variables at Moderate and High Work Rates
Model variables are plotted as a function of x/L, the normalized distance along the capillary. Arterial blood flows into the capillary at x¼0. For all panels,
solid line corresponds to moderate work rate; dashed line corresponds to high work rate. Moderate work rate is defined by setting JAtC¼0.45 mmol s
 1
(l cell)
 1 and G¼0.75 ml min
 1 (g of tissue)
 1; high work rate is defined by setting JAtC¼0.90 mmol s
 1 (l cell)
 1 and G¼1.25 ml min
 1 (g of tissue)
 1.
(A) Cellular pO2 is plotted versus x/L.
(B) Mitochondrial NADH/NADtot is plotted versus x/L.
(C) Mitochondrial cytoC(red)
2þ/cytCtot is plotted versus x/L.
(D) Mitochondrial ATP/ADP is plotted versus x/L.
(E) Mitochondrial membrane potential is plotted versus x/L.
(F) Cytoplasm ATP/Atot is plotted versus x/L.
(G) Cytoplasm ADP concentration is plotted versus x/L.
(H) Cytoplasm Pi concentration is plotted versus x/L.
(I) Cytoplasm CrP/CRtot is plotted versus x/L.
DOI: 10.1371/journal.pcbi.0020107.g004
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Cardiac EnergeticsTo simulate the model response to graded hypoperfusion,
VAtC is set to 0.48 mmol s
 1 (l cell)
 1 and ﬂow is varied from
0.025 to 1.25 ml min
 1 (g of tissue)
 1, corresponding to the
range of coronary blood ﬂows imposed in the study by Zhang
et al. [10]. The value VAtC¼0.48 mmol s
 1 (l cell)
 1 was chosen
to achieve reasonable agreement between the experimental
data and model predictions. Over the range of myocardial
ﬂow, Zhang et al. [10] measured ATP, CrP, Pi, and oxy-
myoglobin saturation (SMb), in dog myocardium in vivo. These
data are compared to steady-state model predictions in
Figure 5. The raw data from Zhang et al. [10] were normalized
so that the measured ATP concentration at normal ﬂow was
equal to 6.5 mM, the model-predicted ATP concentration for
normoxic nonischemic conditions. The same scaling that was
applied to the raw data for ATP was applied to the raw CrP
and Pi data to obtain estimates of the molar concentrations
of these species.
Asexpected,ATP,CrP,andSMblevelsdropandcytoplasmPi
increasesasﬂowisreduced.Ingeneral,theorderofmagnitude
and the qualitative trends in the model predictions match the
experimental observations. However, the experimental ob-
servations show a smoother variation with ﬂow in these four
variables than is predicted by the model. The observed
differences between model predictions and observed data of
Figure 5 are expected to be in part accounted for by the fact
that in the current model myocardial heterogeneities in ﬂow
and capillary length are not considered. This issue is discussed
in greater detail in the Discussion section.
Discussion
Control of Phosphate Metabolites
The major ﬁnding of this study is that the integrated model
is able to reproduce experimental observations on ATP, ADP,
CrP, and Pi over a range of workload and during coronary
hypoperfusion. The integrated model explains metabolite
levels observed at low to moderate workloads and the changes
in metabolite levels and tissue oxygenation observed during
graded hypoperfusion. The level of agreement between
model predictions and experimental measurements is sig-
niﬁcant because the integrated model introduces only a
single adjustable parameter. During a 10-fold increase in
workload (rates of ATP and oxygen consumption), the
cytoplasmic ATP, ADP, and CrP concentrations and mito-
chondrial NADH concentrations are predicted to change
little. The cytoplasmic Pi concentration is predicted to
increase from approximately 0.15 mM at an oxygen con-
sumption of 4 lmol min
 1 (g of tissue)
 1 to approximately 1.0
mM at an oxygen consumption of 10 lmol min
 1 (g of
tissue)
 1. Over this range the model predictions closely match
experimental measurements and indicate that cytoplasmic Pi
level is a key regulator of the rate of mitochondrial
respiration. At work rates higher than approximately 12
Figure 5. Model Simulations of Cardiac Energetic Phosphate Metabolite Levels and Myoglobin Saturation during Coronary Hypoperfusion
(A) Model-predicted cytoplasmic ATP concentration as a function of myocardial blood flow.
(B) Model-predicted cytoplasmic CrP concentration as a function of myocardial blood flow.
(C) Model-predicted cytoplasmic Pi concentration as a function of myocardial blood flow. Experimental data are divided into epicardium (epi), midwall
(mid), and endocardium (endo).
(D) Model-predicted mean myoglobin saturation as a function of myocardial blood flow. For all panels, ATP consumption flux is simulated using
Equation 1, and VAtC is set to 0.48 mmol s
 1 (l cell)
 1. Experimental data are for canine and left ventricular myocardium and obtained from Zhang et al.
[10].
DOI: 10.1371/journal.pcbi.0020107.g005
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 1 (g of tissue)
 1, the model predictions of
cytoplasmic ADP and CrP/ATP ratio are slightly elevated
compared to low work states. Total cytoplasmic plus
mitochondrial ADP is effectively constant over the entire
observed range of work rate. In addition, the validated model
provides quantitative predictions of changes in phosphate
metabolites during cardiac ischemia. Comparison of model
predictions to the data of Zhang et al. [10] provides
independent validation of the model. Although these model-
ing results depend on the chosen value of the maximal rate of
ATP consumption (VAtC), the model predictions in the
extreme limits of ﬂow do not depend on the choice of VAtC.
It is signiﬁcant that the predicted Pi concentration of
approximately 14 mM in the zero-ﬂow limit and the
predicted CrP concentration of approximately 12 mM at
the high-ﬂow limit are close to the observations of Zhang et
al. [10].
Previous modeling studies of Korzeniewski et al. [18] have
attributed the myocardium’s ability to maintain homeostatic
concentrations of ATP and CrP over a range of work rates to a
‘‘parallel activation’’ mechanism in which all respiratory
complexes and the rate of substrate dehydrogenation are
increased in synchrony with the rate of ATP consumption.
However, no independent veriﬁcation of the parallel activa-
tion hypothesis exists. In the current analysis, the biophysical
model of cardiac oxidative phosphorylation and mitochon-
drial substrate transport was developed from an entirely
independent set of data on isolated mitochondria [7]. The
observed stability of energy metabolites emerges as a property
of a properly constructed model of cardiac oxygen transport
and mitochondrial metabolism. Thus the current analysis
casts some doubt on the parallel activation hypothesis.
As concluded previously by Saks et al. [19,20], the current
analysis predicts that Pi is an important feedback signal
regulating respiration in cardiomyocytes. However, impor-
tant differences exist between the current model and earlier
models presented by the Saks group [20,21]. Speciﬁcally, the
earlier models have applied an arbitrary scaling to previously
developed models of mitochondrial oxidative phosphoryla-
tion, to match the observed dynamic range of oxygen
consumption in isolated rat heart. The current model scales
the model of isolated mitochondria based on independent
estimates of cardiac mitochondrial volume density, eliminat-
ing an arbitrary ﬁtting parameter necessary in the earlier
models. Studies from the Saks laboratory have also suggested
that coupling between mitochondrial creatine kinase and the
adenine nucleotide translocase system on the mitochondrial
inner membrane plays a role in maintaining metabolic
homeostasis in the heart [20–23]. It will be valuable to
incorporate the Vendelin–Saks model of the mitochondrial
creatine kinase shuttle into the current model to explore its
possible role in regulating respiration and metabolite
concentrations.
The ﬁndings of the current study are consistent with the
observations of Jeneson et al. [24,25] that, in skeletal muscle,
ADP concentrations vary less than approximately 5-fold
between minimum and maximal work rate. The current
model predicts that ADP is 1.3 times higher at MVO2 of 10
lmol min
 1 (g of tissue)
 1 than at MVO2 of 1.7 lmol min
 1 (g
of tissue)
 1. At the maximal MVO2 the predicted ADP
concentration is 2.5 times greater than that at the minimum.
The predicted cardiac Pi concentration is predicted to be too
low to be detectable in NMR at low work rates [0.15 mM at
MVO2 of 4 lmol min
 1 (g of tissue)
 1] and to increase to the
millimolar range at high work rates [1.0 mM at MVO2 of 10
lmol min
 1 (g of tissue)
 1].
Mitochondrial P/O Ratio
The oxidative phosphorylation model predicts that the
cardiac mitochondrial P/O ratio exceeds the value of 2 for
MVO2 greater than 7.8 lmol min
 1 (g of tissue)
 1 or
approximately 200 llO 2 min
 1 (g of tissue)
 1. For lower
values of oxygen consumption, the P/O ratio is less than 2,
indicating that oxidative ATP synthesis is signiﬁcantly less
efﬁcient at moderate work rates than at maximal work rates
in the heart. This behavior is due to the fact that the
predicted oxygen ﬂux necessary to compensate for proton
leak is nearly constant. Thus the relative contribution of
proton leak to oxygen consumption increases with decreasing
MVO2.
Since the oxygen ﬂux associated with the proton leak is
approximately one tenth of MVOmax
2 , the maximal rate of
oxygen consumption, the P/O ratio as a function of MVO2 is
approximately expressed as P/O ¼ 2.5 (MVO2   0.1MVOmax
2 )/
MVO2, where 2.5 is the theoretical maximum obtained by the
model of oxidative phosphorylation in the absence of a leak
current.
Future Considerations
It is likely that additional regulatory mechanisms that are
not currently incorporated into the model may become
important at high work rates. One putatively important signal
is calcium. Cortassa et al. [26] and Jafri et al. [27–29]
developed models of mitochondrial calcium handling and
calcium-dependent activation of the TCA cycle. At high work
rates, increased mitochondrial calcium may provide a feed-
forward signal to stimulate increased dehydrogenase activity.
The current model, which uses a phenomenological function
to drive the reduction of NAD
þ, does not account for the
possible role of calcium signaling in controlling cardiac
respiration. Future work will integrate the detailed kinetics of
the TCA cycle and calcium activation of the Jafri and
Cortassa models into the current model to explore the
impact of calcium signaling on cardiac metabolic regulation.
Previous analysis of oxygen transport in isolated perfused
hearts has revealed that heterogeneities in microvascular
geometry and ﬂow are important in realistically simulating
oxygen transport to cardiac tissue [30,31]. Yet the current
model uses a single-capillary three-region model to simulate
oxygen transport and metabolism. It is likely that the lack of
heterogeneity in the model is responsible in part for the
deviations between model predictions and experimental
measurements of ATP, Pi, CrP, and SMb during hypoperfusion.
The predicted sharp transition from constant metabolite
concentrations at higher ﬂows to linearly decreasing concen-
trations at lower ﬂows is a result of the model being composed
of a single capillary. When ﬂow is high enough to maintain
normoxia, the energy metabolite concentrations are pre-
dicted to be stable. At lower ﬂows, the myoglobin saturation is
directly proportional to the fraction of the cell that is
normoxic, which increases linearly with ﬂow at a constant
work rate. In the future, the current detailed model of cellular
energetics will be ported to simulations in heterogeneous
three-dimensional geometries, such as that described in [30].
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the computational costs of the integrated model are sub-
stantial. Conducting such simulations based on a three-
dimensional model will require signiﬁcant computational
times, substantial optimization of the simulation codes, and/or
increases in available computing resources.
The current model analysis of the data on ﬂow and oxygen
consumption reveals an approximately linear relationship
between whole-heart cardiac perfusion and the rate of ATP
consumption (illustrated in Figure 2A). Yet it has been
observed that local myocardial blood ﬂow can vary regionally
by up to 10-fold in vivo [32–35]. Since oxygen [35] and fatty
acid [36] uptake are tightly proportional to regional ﬂow in
the myocardium, it is proposed that ATP hydrolysis varies
regionally as well. Future studies that link coronary blood
ﬂow, oxygen and substrate transport, cellular and whole-
heart mechanics, and energy metabolism are expected to shed
light on the physiological basis for regional heterogeneities in
substrate delivery in the heart.
Summary
In sum, the integrated model of cardiac oxygen transport
and mitochondrial oxidative phosphorylation is able to
explain a set of data that has persisted unexplained in the
literature for two decades. The model analysis predicts that Pi
is a key regulator of oxidative phosphorylation in the heart,
allowing ATP and CrP levels to remain relatively constant
over a large range of cardiac work rate. The integrated model
provides the basic framework for simulating the metabolic
response of the myocardium to ischemia and hypoxia.
Materials and Methods
Governing equations for oxygen transport. Oxygen transport in
the capillary is governed by advection of the blood, oxygen–
hemoglogin binding and unbinding, and passive permeation between
the blood and the interstitial space. The governing equation for
oxygen in the capillary is
@CO;1
@t
¼ 
qGL
V1
@CO;1
@x
 
a1PS12
V1
ðP1   P2Þð 2Þ
where CO,1(x,t) is the total oxygen concentration in the blood (free
plus hemoglobin-bound oxygen), G is blood ﬂow to the tissue in
volume per unit time per mass of tissue, q is the tissue density in mass
per unit volume, L is the length of the capillary, V1 is the volume of
the capillary region, a1 is the oxygen solubility coefﬁcient in blood,
PS12 is the permeability of the surface area of capillary wall, and P1
and P2 are the oxygen partial pressures in blood and interstitial ﬂuid,
respectively. The capillary oxygen concentration CO,1 is a function of
the distance along the capillary, x, and time, t.
The total oxygen concentration of the capillary region is related to
the partial pressure by
CO;1 ¼ a1P1 þ HctCHbSHb; ð3Þ
where Hct is the hematocrit, CHb is the concentration of oxygen
binding sites in red blood cells, and SHb is the hemoglobin saturation
in red blood cells. The hemoglobin saturation curve is assumed to be
governed by a Hill equation,
SHb ¼
P
nH
1
P
nH
1 þ P
nH
50;Hb
ð4Þ
where P50,Hb is half the partial pressure of O2 saturation in
hemoglobin and nH is the Hill exponent.
Oxygen transport in the interstitial region is governed by passive
permeation of oxygen between the blood and the interstitial ﬂuid and
between the interstitial ﬂuid and the myocyte
@CO;2
@t
¼ 
a1PS12
V2
ðP1   P2Þ 
a1PS23
V2
ðP2   P3Þð 5Þ
where CO,2(x,t) is the oxygen concentration in interstitial region, V2 is
the volume of the interstitial region, PS23 is the permeability surface-
area product for passive permeation between interstitium region and
the parenchymal cell region, and P3 is the partial pressure of the
oxygen in the cell. Oxygen concentration and partial pressure in the
interstitial ﬂuid are related by CO,2 ¼ a2P2, where a2 is the oxygen
solubility coefﬁcient in the interstitial region.
In the cellular region, oxygen transport is governed by passive
permeation and consumption of oxygen in mitochondria
@CO;3
@t
¼
a1PS23
V3
ðP2   P3Þ RMitoCell
JC4
2
  
ð6Þ
where CO,3 is the oxygen concentration in the cellular region, V3 is
the volume of the cellular region, RMitoCell is the ratio of
mitochondrial volume to total cell volume, and JC4 is the ﬂux through
Complex IV in the respiratory chain in units of mass per time per
unit mitochondrial volume. The factor of ½ in the second term on
the RHS of Equation 6 accounts for the fact that JC4 in the
mitochondrial model (described below) represents the ﬂux of
electron pairs through the respiratory chain: one O2 molecule is
consumed for each two pairs of electrons transferred through the
system. Equation 6 assumes that mitochondria are uniformly and
homogeneously distributed in the cellular space.
Total oxygen in the cell is the sum of free oxygen plus myoglobin-
bound oxygen
CO;3 ¼ a3P3 þ CMbSMb; ð7Þ
Where CMb is the myoglobin concentration in the cell and a3 is the
oxygen solubility in the myocyte. The equilibrium myoglobin
saturation SMb is expressed
SMb ¼
P3
P3 þ P50;Mb
; ð8Þ
where P50,Mb is the half-saturation partial pressure for oxygen–
myoglobin binding.
Governing equations for cellular energetics. The differential
equations for species other than oxygen are
@ Hþ ½  x=@t ¼ b
 1 Hþ ½  x
ðþJDH   5JC1   2JC3   4JC4 þð nA   1ÞJF1 þ 2JPiHt   JKH þ JHleÞ=Wx
@½Kþ x=@t ¼ð þ JKHÞ=Wx
@ Mg2þ   
x=@t ¼ð   JMgADPx   JMgATPxÞ=Wx
@½NADH x=@t ¼ð þ JDH   JC1Þ=Wx
@½Q x=@t ¼ð   JC1 þ JC3Þ=Wx
@ cytCðoxÞ
2þ
hi
i
=@t ¼ð   2JC3 þ 2JC4Þ=Wi
@½ATP x=@t ¼ð þ JF1   JANTÞ=Wx
@½mATP x=@t ¼ð þ JMgATPxÞ=Wx
@½mADP x=@t ¼ð þ JMgADPxÞ=Wx
@½Pi x=@t ¼ð   JF1 þ JPiHtÞ=Wx
@½ATP i=@t ¼ð þ JATPt þ JANT þ JAKiÞ=Wi
@½ADP i=@t ¼ð þ JADPt   JANT   2JAKiÞ=Wi
@½AMP i=@t ¼ð þ JAMPt þ JAKiÞ=Wi
@½mATP i=@t ¼ð þ JMgATPiÞ=Wi
@½mADP i=@t ¼ð þ JMgADPiÞ=Wi
PLoS Computational Biology | www.ploscompbiol.org September 2006 | Volume 2 | Issue 9 | e107 1101
Cardiac Energetics@½Pi i=@t ¼ð þ JPit   JPiHtÞ=Wi
@½Mg2þ i=@t ¼ð   JMgADPi   JMgATPiÞ=Wi
@½ATP c=@t ¼ð   RMitoCytoJATPt   RCellCytoJAtC þ JAKcJCKcÞ=Wc
@½ADP c=@t ¼ð   RMitoCytoJADPt þ RCellCytoJAtC   2JAKc   JCKcÞ=Wc
@½AMP c=@t ¼ð   RMitoCytoJAMPt þ JAKcÞ=Wc
@½MgATP c=@t ¼ð þ JMgATPcÞ=Wc
@½MgADP c=@t ¼ð þ JMgADPcÞ=Wc
@½Pi c=@t ¼ð   RMitoCytoJPit þ RMitoCytoJAtCÞ=Wc
@½Mg2þ c=@t ¼ð   JMgADPc   JMgATPcÞ=Wc
@½CrP c=@t ¼ð   JCKcÞ=Wc
@½CrP c=@t ¼ð   JCKcÞ=Wc
@DW=@t ¼ð þ 4JC1 þ 2JC3 þ 4JC4   nA JF1   JANT   JHleÞ=CIM: ð9Þ
In the above set of equations, the subscripts x, i, and c denote
mitochondrial matrix, intermembrane (IM) space, and cytoplasm,
respectively. All of the variables in this set of equations are deﬁned in
Table 1.
In addition to the state variables treated in Equations 1, 4, 5, and 8,
the concentrations of several species are computed
½NAD x ¼ NADtot  ½ NADH x
½QH2 ¼Qtot  ½ Q 
cytCðredÞ
3þ
hi
¼ cytCtot   cytCðoxÞ
2þ
hi
½ADP x ¼ Atot  ½ ATP x
½Cr c ¼ CRtot  ½ CrP c
ð10Þ
where NADtot,Q tot, cytCtot, and Atot are the total concentrations of
NAD(H), ubiquinol, cytochrome c, and adenine nucleotide in the
matrix, respectively, and CRtot is the total creatine plus creatine
phosphate concentration in the cytoplasm.
Parameters that appear in the above equations are described in
detail below. The ﬂuxes that appear on the right-hand side of the
governing equations are tabulated in Table 2. For mitochondrial
species, the governing equations follow from [7]. For cytoplasmic
species, the reactions modeled are ATP consumption, creatine kinase
reaction, adenylate kinase reaction, and transport between the
cytoplasm and the mitochondrial IM space.
Mathematical expressions for mitochondrial ﬂuxes. Flux expres-
sions for the mitochondrial model (based on a previously developed
model[7]) arelisted below.Deﬁnitionsofthevariables andparameters
that appear in the following expressions are listed in Tables 2 and 3.
Dehydrogenase ﬂux:
JDH ¼ XDH
1 þ½ Pi x=kPi;1
1 þ½ Pi x=kPi;2
  
ðr½NAD x  ½ NADH xÞð 11Þ
Complex I ﬂux:
JC1 ¼ XC1
e
  DG0;C1þ4DGH RTln Hþ ½  x=10 7 ðÞ ðÞ =RT½NADH x½Q  ½ NAD x½QH2 
  
;
ð12Þ
where DGH ¼ FDW þ RT1n([H
þ]c/H
þ]x).
Complex III ﬂux:
JC3 ¼ XC3
1 þ½ Pi x=kPi;3
1 þ½ Pi x=kPi;4
  
e ðDG0;C3þ4DGH 2FDWÞ=2RT cytCðoxÞ
3þ
hi
QH2
   1=2  ½ cytCðredÞ
2þ ½Q 
1=2
  
:
ð13Þ
Complex IV ﬂux:
JC4 ¼ XC4
½O2 
½O2 þkO2
   cytCðredÞ
2þ
hi
cytCtot
e
  DG0;C4þ2DGH 2RTln Hþ ½  x=10 7 ðÞ ðÞ =2RT cytC red ðÞ
2þ  O2 ½ 
1=4
h  
 eþFDW=RT cytCðoxÞ
3þ1
hi  
; ð14Þ
where [O2] ¼ a3P3 is the free oxygen concentration in the cell.
Table 2. Model Fluxes
Category Flux Description Units
Mitochondrial matrix reactions JDH Mitochondrial dehydrogenase mol s
 1 (l mito)
 1
JC1 Complex I mol s
 1 (l mito)
 1
JC3 Complex III mol s
 1 (l mito)
 1
JC4 Complex IV mol s
 1 (l mito)
 1
JF1 F0F1-ATPase reaction mol s
 1 (l mito)
 1
JANT Adenine nucleotide translocase mol s
 1 (l mito)
 1
JPiHt Phosphate–hydrogen cotransporter mol s
 1 (l mito)
 1
JHle Proton leak mol s
 1 (l mito)
 1
JKH Mitochondrial K
þ/H
þ exchanger mol s
 1 (l mito)
 1
JMgATPx Mg
2þ/ATP binding in matrix mol s
 1 (l mito)
 1
JMgADPx Mg
2þ/ADP binding in matrix mol s
 1 (l mito)
 1
Mitochondrial IM space reactions JAKi Adenylate kinase flux in IM space mol s
 1 (l mito)
 1
JMgATPi Mg
2þ/ATP binding in IM space mol s
 1 (l mito)
 1
JMgADPi Mg
2þ/ADP binding in IM space mol s
 1 (l mito)
 1
Mitochondrial transport fluxes JPit Phosphate transport across outer membrane mol s
 1 (l mito)
 1
JATPt ATP transport across outer membrane mol s
 1 (l mito)
 1
JADPt ADP transport across outer membrane mol s
 1 (l mito)
 1
JAMPt AMP transport across outer membrane mol s
 1 (l mito)
 1
Cytoplasmic reactions JAKc Adenylate kinase flux in cytoplasm mol s
 1 (l cytoplasm)
 1
JCKc Creatine kinase flux in cytoplasm mol s
 1 (l cytoplasm)
 1
JMgATPc Mg
2þ/ATP binding in cytoplasm mol s
 1 (l cytoplasm)
 1
JMgADPc Mg
2þ/ADP binding in cytoplasm mol s
 1 (l cytoplasm)
 1
DOI: 10.1371/journal.pcbi.0020107.t002
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Category Parameter Description Value Units Reference
Oxygen transport parameters a1 Plasma O2 solubility 1.30 3 10
 6 Mm mH g
 1 [42]
a2 Interstitial fluid O2 solubility 1.25 3 10
 -6 Mm mH g
 1 [43]
a3 Myocyte O2 solubility 1.74 3 10
 6 Mm mH g
 1 [44]
PS12 Capillary wall PS product 50 ml s
 1 (ml tissue)
 1 [38,39]
PS23 Myocyte fiber PS product 10 ml s
 1 (ml tissue)
 1 [45]
Hct Hematocrit 0.45 unitless
CHb Oxyhemoglobin binding site concentration 0.0213 mol (l RBC)
 1 [42]
P50,Hb Hemoglobin half-saturation PO2 30.0 mm Hg [46]
nH Hemoglobin Hill coefficient 2.55 unitless [46]
CMb Myoglobin concentration 200 3 10
 6 mol (l cell)
 1
P50,Mb Myoglobin half-saturation PO2 2.39 mm Hg [47]
Pinput Arterial oxygen PO2 100 mm Hg
Structure/volume parameters q Tissue density 1.053 g (ml tissue)
 1 [37]
L Capillary length 550 lm [40]
V1 Capillary blood volume 0.05 ml (ml tissue)
 1 [36,48]
a
V2 Interstitial volume 0.17585 ml (ml tissue)
 1 [37]
V3 Cell volume 0.73078 ml (ml tissue)
 1 [37]
Wx Matrix water space fraction 0.6514 l water (l mito)
 1 [7,37]
Wi IM space water fraction 0.0724 l water (l mito)
 1 [7,37]
Wc Cytoplasm water fraction 0.8425 l water (l cytoplasm)
 1 [37]
RMitoCell Mitochondrial/cell volume ratio 0.2882 l mito (l cell)
 1 [37]
RMitoCyto Mitochondrial/cytoplasm volume ratio 0.4237 l mito (l cell)
 1 [37]
RCellCyto Cell/cytoplasm volume ratio 1.4703 l cell (l cytoplasm)
 1 [37]
c Outer membrane area per mito volume 5.99 lm
 1 [49]
Physicochemical parameters RT Gas constant times temperature 2.5775 kJ mol
 1 –
b
F Faraday’s constant 0.096484 kJ mol
 1 mV
 1 –
b
DGO,C1 Standard free energy, Complex I –69.37 kJ mol
 1 [50]
c
DGO,C3 Standard free energy, Complex III –32.53 kJ mol
 1 [50]
c
DGO,C4 Standard free energy, Complex IV –122.94 kJ mol
 1 [50]
c
DGO,ATP Standard free energy, ATPase 36.03 kJ mol
 1 [50]
c
Mitochondrial model parameters R Dehydrogenase model parameter 4.559 unitless [7,41]
d
kPi,1 Dehydrogenase model parameter 0.1553 mM [7,41]
d
kPi,2 Dehydrogenase model parameter 0.8222 mM [7,41]
d
XDH Dehydrogenase activity 0.0866 mol s
 1 M
 1 (l mito)
 1 [7,41]
d
XC1 Complex I activity 4.405 3 10
3 mol s
 1 M
 2 (l mito)
 1 [7,41]
d
XC3 Complex III activity 4.887 mol s
 1 M
 3/2 (l mito)
 1 [7,41]
d
XC4 Complex IV activity 6.766 3 10
 5 mol s
 1 M
 1 (l mito)
 1 [7,41]
d
XF1 F0F1-ATPase activity 1000 mol s
 1 M
 1 (l mito)
 1 [7,41]
d
XANT ANT activity 8.123 3 10
 3 mol s
 1 (l mito)
 1 [7,41]
d
XPiHt H
þ/Pi
  cotransport activity 3.850 3 10
5 mol s
 1 M
 1 (l mito)
 1 [7,41]
d
kPiHt H
þ/Pi
  cotransport parameter 0.2542 mM [7,41]
d
XKH K
þ/H
þ antiporter activity 5.651 3 10
7 mol s
 1 M
 2 (l mito)
 1 [7,41]
d
XHle Proton leak activity 200.00 mol s
 1 M
 1 mV
 1 (l mito)
 1 [7,41]
d
kPi,3 Complex III/Pi parameter 0.3601 mM [7,41]
d
kPi,4 Complex III/Pi parameter 5.924 mM [7,41]
d
nA H
þ stoich. coefficient for F0F1-ATPase 3 unitless [51]
pPi Mitochondrial membrane permeability to Pi 327 lms
 1 [20]
pA Mitochondrial outer membrane permeability
to nucleotides
85.0 lms
 1 [52]
km,ADP ANT Michaelis-Menten constant 3.5 3 10
 6 M [20,53]
e
kO2 Kinetic constant for Complex IV 1.2 3 10
 4 M [20,53]
e
b Matrix buffering capacity 0.01 M [20,53]
e
CIM Capacitance of inner membrane 6.75 3 10
 6 mol (l mito)
 1 mV
 1 [7,54]
Fixed concentrations and
concentration pools
NADtot Total matrix NAD(H) concentration 2.97 mol (l matrix water)
 1 [20,53]
e
Qtot Total matrix ubiquinol concentration 1.35 mol (l matrix water)
 1 [20,53]
e
cytCtot Total IM cytochrome c concentration 2.70 mol (l IM water)
 1 [20,53]
e
Atot Total matrix ATP þ ADP concentration 10 mol (l matrix water)
 1 [20,53]
e
TPP Total phosphate pool (see text) 12
 18 mmol (l cell)
 1 –
[H
þ]c Cytoplasm H
þ ion concentration 10
 7.1 mol (l cytoplasm water)
 1
[K
þ]c Cytoplasm K
þ ion concentration 150 mol (l cytoplasm water)
 1
Binding constants CRtot Total Cr þ CrP concentration 40.14 mol (l cytoplasm water)
 1 [5]
f
KAK Adenylate kinase equilibrium constant 0.4331 unitless [50]
c
KCK Creatine kinase equilibrium constant 1.66 3 10
9 M
 1 [55]
KMg-ATP Mg-ATP binding constant 24 3 10
 6 M [56]
KMg-ADP Mg-ADP binding constant 347 3 10
 6 M [56]
XAK Adenylate kinase activity 1 3 10
7 Ms
 1 M
 2 –
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JF1 ¼ XF1 e ðDG0; ATP nADGHÞ=RT KMg-ADP
KMg-ATP
½mADP x½Pi x  ð 1MÞ½mATP x
  
:
ð15Þ
Magnesium binding ﬂuxes:
JMgATPx ¼ XMgAð½fATP x Mg2þ ½  x   KMg-ATP½mATP xÞ
JMgADPx ¼ XMgAð½fADP x Mg2þ ½  x   KMg-ADP½mADP xÞ
JMgATPi ¼ XMgAð½fATP i½Mg2þ i   KMg-ATP½mATP iÞ
JMgADPx ¼ XMgAð½fATP i½Mg2þ i   KMg-ADP½mADP iÞ
ð16Þ
where [fATP]x, [fADP]x, [fATP]i, and [fADP]i denote magnesium
unbound ATP in the matrix, ADP in the matrix, ATP in the IM space,
and ADP in the IM space, respectively.
Substrate transport ﬂuxes:
JATPt ¼ cpAð½ATP c  ½ ATP iÞ
JADPt ¼ cpAð½ADP c  ½ ADP iÞ
JAMPt ¼ cpAð½AMP c  ½ AMP iÞ
JPit ¼ cpPið½Pi c  ½ Pi iÞð 17Þ
Adenine nucleotide translocase (ANT) ﬂux:
JANT ¼ XANT
½fADP i
½fADP i þ½ fATP ie 0:35FDW=RT  
½fADP x
½fADP x þ½ fATP xe 0:65FDW=RT
  
1
1 þ km;ADP=½fADP i
  
: ð18Þ
The phosphate–hydrogen cotransporter ﬂux:
JPiHt ¼ XPiHt
½H2PO 
4  i½Hþ c  ½ H2PO 
4  x½Hþ x
½H2PO 
4  i þ kPiHt
  
; ð19Þ
where [H2PO 
4 ]i ¼ [H
þ]i[Pi]i/([H
þ]i þ kdH) and [H2PO 
4 ]x ¼ [H
þ]x[Pi]x/
([H
þ]x þ kdH).
Mitochondrial adenylate kinase ﬂux:
JAKi ¼ XAKðKAK½ADP i½ADP i  ½ AMP i½ATP iÞ: ð20Þ
Proton leak ﬂux:
JHle ¼ XHleDW
½Hþ ceþFDW=RT  ½ Hþ x
eþF DW=RT   1
  
: ð21Þ
Potassium–hydrogen ion exchange:
JKH ¼ XKHð½Kþ c½Hþ x  ½ Kþ x½Hþ cÞ: ð22Þ
The above expressions for the mitochondrial model ﬂuxes are
identical to those presented in [7], with the exception of the Complex
I and III ﬂuxes, which have been modiﬁed to ensure that the model
remains numerically stable when [O2] and [Q] reach 0.
Mathematical expressions for cytoplasmic reaction ﬂuxes. Four
biochemical processes are modeled in the cytoplasm—the adenylate
kinase reaction, the creatine kinase reaction, ATP hydrolysis, and
binding of magnesium ions to ADP and ATP.
The binding of magnesium to ATP and ADP in the cytoplasm takes
the same form as the binding ﬂuxes in the mitochondria:
JMgATPc ¼ XMgAð½fATP c½Mg2þ c   KMg-ATP½mATP cÞ
JMgADPc ¼ XMgAð½fADP c½Mg2þ c   KMg-ADP½mADP cÞ ð23Þ
where [fATP]c and [fADP]c denote magnesium unbound ATP and
ADP in the cytoplasm. Similarly, the cytoplasmic adenylate kinase is
analogous to the mitochondrial reaction.
JAKc ¼ XAKðKAK½ADP c½ADP c  ½ AMP c½ATP cÞð 24Þ
In Equation 24, KAK is the equilibrium constant for the reaction 2
ADP ATP þ AMP, and XAK is the enzyme activity, which is set to a
large enough value so that the reaction is effectively maintained in
equilibrium.
The creatine kinase ﬂux is modeled using the expression:
JCKc ¼ XCKðKCK½ADP c½CrP c½Hþ c  ½ ATP c½Cr cÞ; ð25Þ
where the activity XCK is set to a large enough value so that the
equilibrium KCK ¼ ([ATP]c[Cr]c/[ADP]c[CrP]c[H
þ]c)eq is maintained
during simulations.
The ﬂux JAtC is deﬁned as the ﬂux through the reaction ATP !
ADP þ Pi. Mathematical models for the ATP consumption ﬂux are
considered in the Results section.
Parameter values. With the exception of one adjustable parameter,
all parameters in the model are ﬁxed at values justiﬁed by previous
studies. The adjustable parameter is the total pool of exchangeable
phosphate in the cell, which is a constant denoted by TPP. The total
exchangeable phosphate pool is computed as
TPP ¼½ VcytoWcð2½ATP c þ½ ADP c þ½ Pi c þ½ CrP cÞ
þVmitoWið2½ATP i þ½ ADP i þ½ Pi iÞ
þVmitoWxð½ATP x þ½ Pi xÞ =Vcell ð26Þ
where Vcyto ¼ 0.472 ml (g of tissue)
 1, Vmito ¼ 0.200 ml (g of tissue)
 1,
and Vcell ¼ 0.694 ml (g of tissue)
 1 are the volume densities of
cytoplasm, mitochondria, and total cell space in cardiac tissue [37]. By
comparing simulation predictions with experimental data (see
Results section), a value of TPP ¼ 15 mM is chosen as the value most
consistent with the experimental observations.
The parameter values listed in Table 3 are organized into oxygen
transport parameters, structure/volume parameters, physicochemical
parameters, mitochondrial model parameters, ﬁxed concentration
pools, and binding constants.
The oxygen transport parameters, including solubilities, perme-
abilities, and oxyhemoglobin and oxymyoglobin binding parameters,
are obtained from the literature, as indicated in the table. The
effective permeability–surface area product for the capillary wall is
obtained by converting the mass transfer coefﬁcient reported in [38]
and used in [39] to the corresponding PS product. Similarly, the
structure/volume parameters are available from experimental esti-
mations published in the literature. The effective capillary length is
set to the mean capillary path length for left ventricular tissue
reported by Kassab and Fung [40]. The majority of the volume density
and water space measurements are obtained from the study of
Table 3. Continued
Category Parameter Description Value Units Reference
XCK Creatine kinase activity 1 3 10
7 Ms
 1 M
 2 –
XMgA Mg
2þ binding activity 1 3 10
7 Ms
 1 M
 2 –
kdH H2PO4 proton dissociate constant 1.78 3 10
 7 M [50]
aValue is within range of standard values used for dog heart found in cited references.
bStandard physicochemical constants.
cComputed from thermodynamic data tabulated in cited reference.
dValue set by fitting the data in cited references; see text for explanation.
eValue used is taken from previous modeling studies, not direct experimental measure.
fValue is computed from [27.3 mmol (l cell water)
 1] 3 [1.4703 l cell (l cytoplasm)
 1].
DOI: 10.1371/journal.pcbi.0020107.t003
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model parameters are estimated and reported in [7].
Oxidative phosphorylation model parameters have been adjusted
to account for modiﬁcations from [7], as indicated in the table. Since
the F0F1-ATPase reaction is maintained near chemical equilibrium in
the model parameterization that was published in [7], here the F0F1-
ATPase activity XF1 is set to the arbitrarily high value of 1,000 mol s
 1
M
 1 (l mito)
 1. In addition, the updates to the functional forms for the
Complex I and III ﬂuxes require estimation of values for the activities
of XC1 and XC3. To account for these changes, the full set of
mitochondrial model parameters has been reﬁned by repeating the
ﬁts to data from isolated mitochondrial function of Beard [7]. The
agreement between the data of Bose et al. [41] and the updated model
is equivalent to that reported for theprevious versionof the model [7].
All values for concentrations of pooled metabolites are set
according to values reported in previous studies, with the exception
of the total pool of exchangeable phosphate (TPP), which is estimated
in the Results section. Binding constants are obtained from the
literature; enzyme activities for reactions maintained near equili-
brium are set to arbitrarily high values.
Computational methods. The model was coded using MATLAB;
multiple steady-state solutions were obtained using the Matlab
Distributed Computing Toolbox on 25-node cluster (50-CPU AMD
Opteron-based server HP DL145 G2 with dual 2.6-GHz processors).
Obtaining a single steady-state solution requires approximately 30
min of computing time on a single processor. A total of 150 steady-
state solutions are computed to construct Figure 4, requiring less
than 2 h to complete using the cluster.
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